Bordetella pertussis toxoid antigen (formaldehyde inactivated) Completed Phase 4 Trials for Poliomyelitis / Diphtheria / Acellular Pertussis / Tetanus / Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines Prevention

Indications	Status	Purpose	Phase
DBCOND0013769 (Poliomyelitis) DBCOND0000394 (Diphtheria) DBCOND0031302 (Acellular Pertussis) DBCOND0000386 (Tetanus) DBCOND0121368 (Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02422264	Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Hepatitis B Vaccine (Recombinant) (DB11627) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)